Literature DB >> 20826584

Specifically PNPLA3-mediated accumulation of liver fat in obese patients with type 2 diabetes.

Jean-Michel Petit1, Boris Guiu, David Masson, Laurence Duvillard, Valerie Jooste, Perrine Buffier, Beatrice Terriat, Benjamin Bouillet, Marie-Claude Brindisi, Romaric Loffroy, Isabelle Robin, Patrick Hillon, Jean-Pierre Cercueil, Bruno Verges.   

Abstract

CONTEXT: Recently, it has been shown in the general population that an allele in the adiponutrin (PNPLA3) gene was strongly associated with increased liver fat content (LFC), independently of visceral adiposity and insulin resistance.
OBJECTIVE: In this study, we set out to determine whether LFC, evaluated using (1)H-MR spectroscopy, was associated with PNPLA3 rs738409 polymorphism in people with type 2 diabetes. We also evaluated the influence of this polymorphism on the relationship between LFC and either visceral adiposity or carotid intima media thickness (CIMT). DESIGN, SETTINGS, AND PARTICIPANTS: A total of 218 type 2 diabetic patients were included in this study. MAIN OUTCOME MEASURES: LFC, area of visceral fat, and CIMT were measured.
RESULTS: A total of 139 (63.7%) patients had steatosis. The rs738409 minor G allele was associated with LFC. The number of patients with steatosis was significantly higher among minor G allele carriers in comparison to C allele homozygote carriers (70.3 vs. 57.2%; P=0.04) In the subgroup of C allele homozygote carriers, LFC correlated with body mass index (r=0.27; P=0.003) and visceral fat area (r=0.30; P=0.002), but not with CIMT. In the subgroup of minor G allele carriers, LFC correlated inversely with CIMT (r=-0.23; P=0.03), but not with body mass index or with visceral fat area. In multivariate logistic regression, the relationship between the highest quartile of CIMT and steatosis was different according to adiponutrin polymorphism.
CONCLUSIONS: This study confirms that in people with type 2 diabetes, LFC is related to rs738409 polymorphism. The lack of a relationship with visceral obesity and the inverse correlation with CIMT suggest that fatty liver associated with the minor G allele of the PNPLA3 rs738409 polymorphism may not be linked to metabolic disorders.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20826584     DOI: 10.1210/jc.2010-0814

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  14 in total

Review 1.  PNPLA3 I148M variant in nonalcoholic fatty liver disease: demographic and ethnic characteristics and the role of the variant in nonalcoholic fatty liver fibrosis.

Authors:  Li-Zhen Chen; Yong-Ning Xin; Ning Geng; Man Jiang; Ding-Ding Zhang; Shi-Ying Xuan
Journal:  World J Gastroenterol       Date:  2015-01-21       Impact factor: 5.742

2.  Association of PNPLA3 SNP rs738409 with liver density in African Americans with type 2 diabetes mellitus.

Authors:  A J Cox; M R Wing; J J Carr; R C Hightower; S C Smith; J Xu; L E Wagenknecht; D W Bowden; B I Freedman
Journal:  Diabetes Metab       Date:  2011-06-14       Impact factor: 6.041

Review 3.  Genetic determinants of hepatic steatosis in man.

Authors:  Amanda J Hooper; Leon A Adams; John R Burnett
Journal:  J Lipid Res       Date:  2011-01-18       Impact factor: 5.922

4.  PNPLA3, the triacylglycerol synthesis/hydrolysis/storage dilemma, and nonalcoholic fatty liver disease.

Authors:  Silvia Sookoian; Carlos J Pirola
Journal:  World J Gastroenterol       Date:  2012-11-14       Impact factor: 5.742

5.  Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma.

Authors:  John C Chambers; Weihua Zhang; Joban Sehmi; Xinzhong Li; Mark N Wass; Pim Van der Harst; Hilma Holm; Serena Sanna; Maryam Kavousi; Sebastian E Baumeister; Lachlan J Coin; Guohong Deng; Christian Gieger; Nancy L Heard-Costa; Jouke-Jan Hottenga; Brigitte Kühnel; Vinod Kumar; Vasiliki Lagou; Liming Liang; Jian'an Luan; Pedro Marques Vidal; Irene Mateo Leach; Paul F O'Reilly; John F Peden; Nilufer Rahmioglu; Pasi Soininen; Elizabeth K Speliotes; Xin Yuan; Gudmar Thorleifsson; Behrooz Z Alizadeh; Larry D Atwood; Ingrid B Borecki; Morris J Brown; Pimphen Charoen; Francesco Cucca; Debashish Das; Eco J C de Geus; Anna L Dixon; Angela Döring; Georg Ehret; Gudmundur I Eyjolfsson; Martin Farrall; Nita G Forouhi; Nele Friedrich; Wolfram Goessling; Daniel F Gudbjartsson; Tamara B Harris; Anna-Liisa Hartikainen; Simon Heath; Gideon M Hirschfield; Albert Hofman; Georg Homuth; Elina Hyppönen; Harry L A Janssen; Toby Johnson; Antti J Kangas; Ido P Kema; Jens P Kühn; Sandra Lai; Mark Lathrop; Markus M Lerch; Yun Li; T Jake Liang; Jing-Ping Lin; Ruth J F Loos; Nicholas G Martin; Miriam F Moffatt; Grant W Montgomery; Patricia B Munroe; Kiran Musunuru; Yusuke Nakamura; Christopher J O'Donnell; Isleifur Olafsson; Brenda W Penninx; Anneli Pouta; Bram P Prins; Inga Prokopenko; Ralf Puls; Aimo Ruokonen; Markku J Savolainen; David Schlessinger; Jeoffrey N L Schouten; Udo Seedorf; Srijita Sen-Chowdhry; Katherine A Siminovitch; Johannes H Smit; Timothy D Spector; Wenting Tan; Tanya M Teslovich; Taru Tukiainen; Andre G Uitterlinden; Melanie M Van der Klauw; Ramachandran S Vasan; Chris Wallace; Henri Wallaschofski; H-Erich Wichmann; Gonneke Willemsen; Peter Würtz; Chun Xu; Laura M Yerges-Armstrong; Goncalo R Abecasis; Kourosh R Ahmadi; Dorret I Boomsma; Mark Caulfield; William O Cookson; Cornelia M van Duijn; Philippe Froguel; Koichi Matsuda; Mark I McCarthy; Christa Meisinger; Vincent Mooser; Kirsi H Pietiläinen; Gunter Schumann; Harold Snieder; Michael J E Sternberg; Ronald P Stolk; Howard C Thomas; Unnur Thorsteinsdottir; Manuela Uda; Gérard Waeber; Nicholas J Wareham; Dawn M Waterworth; Hugh Watkins; John B Whitfield; Jacqueline C M Witteman; Bruce H R Wolffenbuttel; Caroline S Fox; Mika Ala-Korpela; Kari Stefansson; Peter Vollenweider; Henry Völzke; Eric E Schadt; James Scott; Marjo-Riitta Järvelin; Paul Elliott; Jaspal S Kooner
Journal:  Nat Genet       Date:  2011-10-16       Impact factor: 38.330

6.  The PNPLA3 rs738409 148M/M genotype is a risk factor for liver cancer in alcoholic cirrhosis but shows no or weak association in hepatitis C cirrhosis.

Authors:  Hans Dieter Nischalke; Cordula Berger; Carolin Luda; Thomas Berg; Tobias Müller; Frank Grünhage; Frank Lammert; Martin Coenen; Benjamin Krämer; Christian Körner; Natascha Vidovic; Johannes Oldenburg; Jacob Nattermann; Tilman Sauerbruch; Ulrich Spengler
Journal:  PLoS One       Date:  2011-11-07       Impact factor: 3.240

7.  The role of mitochondrial genomics in patients with non-alcoholic steatohepatitis (NASH).

Authors:  Rohini Mehta; Kianoush Jeiran; Aaron B Koenig; Munkzhul Otgonsuren; Zachary Goodman; Ancha Baranova; Zobair Younossi
Journal:  BMC Med Genet       Date:  2016-09-05       Impact factor: 2.103

8.  PNPLA3 as a Genetic Determinant of Risk for and Severity of Non-alcoholic Fatty Liver Disease Spectrum.

Authors:  Habeeb Salameh; Muhannad Al Hanayneh; Maen Masadeh; Mohammed Naseemuddin; Tasnia Matin; Angelika Erwin; Ashwani K Singal
Journal:  J Clin Transl Hepatol       Date:  2016-07-08

9.  Nod2 and Nod2-regulated microbiota protect BALB/c mice from diet-induced obesity and metabolic dysfunction.

Authors:  Ivan Rodriguez-Nunez; Tiffany Caluag; Kori Kirby; Charles N Rudick; Roman Dziarski; Dipika Gupta
Journal:  Sci Rep       Date:  2017-04-03       Impact factor: 4.379

Review 10.  Causes of changes in carotid intima-media thickness: a literature review.

Authors:  Baoge Qu; Tao Qu
Journal:  Cardiovasc Ultrasound       Date:  2015-12-15       Impact factor: 2.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.